News Updates
More Articles
- WHO warns of vaccine inequity, more monkeypox deaths
- ViiV, Medicines Patent Pool in licensing deal for cabotegravir
- Ipsen partners with Marengo in deal worth up to $1.6B
- EliTech, InfanDx sign MoU for encephalopathy test
- Hong Kong OKs Sinovac vaccine for kids 6 months to 3 years
EUnetHTA21 Launches Joint Scientific Consultations for Regulators, HTAs, and Sponsors
The aim of the new health technology assessment (HTA) regulation is to secure timely patient access to novel therapies, to avoid duplicative HTA-assessment work at the Member State level, and to provide the sector with a predictable and consistent HTA process.
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!